← All Ing Groep NV filings

Ing Groep NV Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
ING
Ing Groep NV
SCHEDULE: ING Groep Discloses 3.99% Stake in NEOGEN Corp
ING Groep N.V. and its subsidiary, ING Capital Markets LLC, have reported a shared beneficial ownership of 3.99% in NEOGEN Corp's common stock.
NYSE
ING
Ing Groep NV
SCHEDULE: ING Groep Discloses 6.47% Stake in NEOGEN CORP
ING Groep N.V. and its subsidiary, ING Capital Markets LLC, have jointly disclosed a beneficial ownership of 6.47% in NEOGEN CORP's common stock.
NYSE
ING
Ing Groep NV
SCHEDULE 13G/A: Capital Research Global Investors Discloses 4.8% Stake in ING Groep NV
Capital Research Global Investors has filed an amended Schedule 13G, reporting a beneficial ownership of 4.8% in ING Groep NV as of December 31, 2024.